51° SUNNY, Levi dominates Stage 5
Last Modified: Friday, February 22, 2008 at 3:05 p.m.
SOLVANG -- Levi Leipheimer rode to a dominating Stage 5 individual time trial win and extended his race lead Friday in the Amgen Tour of California.
- Levi well-protected midway through final stage
- Three-peat for Levi
- Armstrong admits he's tired
- Armstrong becomes a 'team' rider
- Final overall results of the 2009 Tour of California
- Leipheimer keeps TOC lead heading into final stage
- Overall TOC standings after Stage 7
- Clement early time trial leader
- Leipheimer wins time trial, overall lead now 36 seconds
- Overall standings after Stage 6
- Power meter has become indispensable tool for pro riders
- Overall standings after Stage 5
- Friday is "showdown" day
- Overall TOC results after Stage 4
- Leipheimer holds overall lead in Tour of California
- More Stories
Leipheimer (Astana) of Santa Rosa, who began the day with a 13-second margin over of Fabian Cancellara (CSC) of Switzerland, completed the 15-mile course in 30 minutes and 46 seconds and was the only cyclist to eclipse 31 minutes.
David Milar (Slipstream-Chipotle) of Great Britain, who began the day in fourth place overall, finished second in 31:15 and moved into second place, trailing Leipheimer by 49 seconds.
Christian Vande Velde (Slipstream-Chipotle) of Lemont, Ill., was third in the stage, finishing in 31:31.
The seven-stage, eight-day event continues Saturday with the 105-mile Santa Barbara to Santa Clarita road race.
All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.
Add a Comment
Only moderator-approved comments are shown on this page. To see all comments, please visit the forum. We at PressDemocrat.com created these forums as a place where our community can exchange ideas on news issues and express their thoughts. Please be courteous and respectful. Avoid expletives, false statements, veiled or overt threats and personal attacks. Stay on topic. (View full Terms of Service.)Post a comment | View all comments on this topic.